RecruitingBreast CancerAnthracycline Related Cardiotoxicity in Breast CancerVirtual Reality
Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab
Eligible age
18+ yrs
Accepts
Women
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The main goal of this study is to test a virtual reality (VR) program, Survivors' Virtual Reality Survivorship Experience (SurviVRSE), designed to help Breast Cancer survivors (n=30) learn about heart health. The aims are to test the usability, feasibility, and acceptability o the intervention. Additionally, follow-up assessments will examine changes in women's cancer therapy related cardiac dysfunction knowledge and heart healthy behaviors (e.g., physical activity).
Sponsor: Virginia Commonwealth University
You may qualify if…
- ✓ 18 years of age or older
- ✓ Able to speak and read in English
- ✓ Actively receiving Trastuzumab or an anthracycline-based treatment
- ✓ Currently receiving immunotherapy. This includes pembrolizumab and atezolizumab.
- ✓ Diagnosed with stages 0-III Breast Cancer
You may not qualify if…
- ✕ \- History of prior Breast Cancer diagnosis (i.e., not their first breast cancer diagnosis)
Where it's recruiting
Virginia
Richmond
Source: ClinicalTrials.gov · NCT07426913 · last updated 2026-07-02